A novel xenonucleic acid-mediated molecular clamping technology for early colorectal cancer screening

• Qing Sun ,

  Roles Conceptualization, Investigation, Supervision, Validation, Writing – original draft, Writing – review & editing

  * E-mail: msha@diacarta.com (MYS); qsun@diacarta.com (QS)

  Affiliation DiaCarta, Inc., Richmond, California, United States of America

  ⨯
• Larry Pastor,

  Roles Data curation, Methodology

  Affiliation DiaCarta, Inc., Richmond, California, United States of America

  ⨯
• Jinwei Du,

  Roles Data curation, Methodology

  Affiliation DiaCarta, Inc., Richmond, California, United States of America

  ⨯
• Michael J. Powell,

  Roles Conceptualization, Methodology, Supervision

  Affiliation DiaCarta, Inc., Richmond, California, United States of America

  ⨯
• Aiguo Zhang,

  Roles Conceptualization, Funding acquisition, Project administration, Supervision

  Affiliation DiaCarta, Inc., Richmond, California, United States of America

  ⨯
• Walter Bodmer,

  Roles Supervision, Writing – review & editing

  Affiliation Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, Oxford, United Kingdom

  ⨯
• Jianzhong Wu,

  Roles Investigation, Resources

  Affiliation Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research, Nanjing, China

  ⨯
• Shu Zheng,

  Roles Resources, Supervision

  Affiliation The Second Affiliated Hospital Zhejiang University, Hangzhou, China

  ⨯
• Michael Y. Sha

  Roles Conceptualization, Investigation, Methodology, Supervision, Validation, Writing – original draft, Writing – review & editing

  * E-mail: msha@diacarta.com (MYS); qsun@diacarta.com (QS)

  Affiliation DiaCarta, Inc., Richmond, California, United States of America

  https://orcid.org/0000-0002-4552-6079

  ⨯